🇺🇸 FDA
Patent

US 7659403

Biphenyl compounds useful as muscarinic receptor antagonists

granted A61PA61P11/00

Quick answer

US patent 7659403 (Biphenyl compounds useful as muscarinic receptor antagonists) held by Theravance, Inc. expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61P, A61P11/00